Guidance for Treating Pregnant Women with Opioid Use Disorder Released

Feb 08, 2018 - 12:48 PM

The Substance Abuse and Mental Health Services Administration today issued new clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants. The guidance consists of 16 factsheets containing clinical recommendations and resources to help health care professionals make evidence-informed decisions based on individual patient needs and local circumstances. “SAMHSA is filling an urgent need for reliable, useful and accurate information for health care professionals working to treat opioid-dependent mothers and their children,” said Elinore McCance-Katz, SAMHSA assistant secretary for mental health and substance use. “Ultimately, the steps explained in this guidance will help the mother and her infant safely receive treatment for opioid use disorder and neonatal abstinence syndrome.” In other news, the Senate Health, Education, Labor and Pensions Committee today held a hearing on the opioid crisis and its impact on children and families. Witnesses included Stephen Patrick, M.D., a pediatrician and neonatologist at Monroe Carell Jr. Children’s Hospital at Vanderbilt in Nashville and an assistant professor of pediatrics and health policy at Vanderbilt University School of Medicine.
 

Related News Articles

Headline
FDA approves first-in-class non-opioid painkiller 
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
AHA podcast: Englewood Health's Strategies to Combat Rising Opioid Use in Post-Pandemic America
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…
Headline
AHA podcast: Thinking Outside the Box to Reduce Behavioral Health Stigma and Disparities 
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to…
Headline
'Take Back Day' Oct. 28 to dispose safely of prescription drugs
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
Agencies target unapproved pharmaceutical products from India
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…
Headline
AHA sends SUPPORT Act reauthorization recommendations to House committee  
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and…